The Christie NHS Foundation Trust

Dr. McCabe is a clinical senior lecturer in pediatric and adolescent cancer at the University of Manchester. He takes part in the multidisciplinary teams (MDT) for brain tumors at the Salford Royal Hospital, the Royal Manchester Children's Hospital, and the Manchester neurofibromatosis 2 MDT, all of which are located at St Mary's Hospital. Dr. McCabe's laboratory research focuses on pediatric brain tumors and sarcomas. The European research rEECur, which investigates the use of chemotherapy in instances of recurrent or resistant Ewing sarcoma, has him as its lead investigator. View Profile

Hodgkin and non-Hodgkin lymphomas have long been of interest to Professor Radford. He has conducted world-class research in the area, particularly in regards to building the case for PET scan-directed therapy for Hodgkin lymphoma. In the clinical development of brentuximab vedotin, he played a key role. He was chair from 2011 to 2017 and has a long history with the UK NCRI Lymphoma Clinical Studies Group. He oversees the oncology tertiary care/primary care interface subject at the NIHR Manchester Patient Safety Translational Research Centre. He has a particular interest in minimizing late treatment toxicity, especially in second malignancies. Professor Radford runs a busy clinical practice at The Christie, where lymphoma patients from all over the UK seek his advice. He oversaw the development of a vibrant research culture while serving as director of research since 2007. View Profile

Andrew Sykes received his medical degree in Birmingham and then relocated to Manchester to attend The Christie for his oncology residency. In 1997, he was hired as a consultant at The Christie, where he has since developed a specialty in the treatment of head and neck cancer. This covers sophisticated intensity-modulated radiotherapy (IMRT) and the administration of chemotherapy as palliative and adjuvant therapy. Additionally, he uses radiotherapy to treat skin cancer, including melanoma and non-melanoma. He was formerly the Christie Drug and Therapeutics Committee's chairman and is currently the department of clinical oncology's clinical director. View Profile

The Christie NHS Foundation Trust's consultant clinical oncologist is Dr. David Woolf. For patients with breast and lung cancer as well as those whose malignancies have metastasized to other organs, he designs and administers cutting-edge radiation. Dr. Woolf is the specialist at the Christie for stereotactic ablative radiotherapy (SABR/SBRT) and has a wealth of experience in its use. He received his training in the USA and is certified to use proton beam radiotherapy. He also uses the MR Linac to provide radiotherapy. Dr. Woolf also uses targeted medication therapies, such as immunotherapy, chemotherapy, and endocrine therapy, to treat his patients. With this combination of skills, Dr. Woolf may collaborate with specialists from the larger multidisciplinary team, including top surgeons, doctors, and radiologists, to develop a thorough treatment plan for patients. View Profile

Famous onco-urologist Vijay Sangar practices in London. He is employed by The Christie NHS Foundation Trust at the moment. He is the North West Uro-oncology Group's Chair, Lead Penile Clinician for England, and Director of Surgery. Consultant urologist at the University Hospital of South Manchester; chair of the NHS England Specialised Urology Clinical Reference Group; member of the executive committee for the British Association of Urological Surgeons' sections of oncology and andrology. Expert urologist surgeon Mr. Sangar. Prior to accepting his Consultant position at the Christie in 2007, he completed his surgical and urological training (FRCS (Urol)) in London, the North West, and Strasbourg after receiving his degree from the University of Manchester. His primary area of expertise is men's health, and he is well-known across the country for his expertise in penile surgery, particularly in cases of cancer. He also has extensive experience doing difficult pelvic cancer surgeries and diagnosing urological cancer. He is a member of one of the top teams fighting pelvic cancer in the UK. His interest in men's health includes peyronies disease, infertility, scrotal issues, and erectile dysfunction. Mr. Sangar's research focuses mostly on penile cancer, and he has contributed significantly to creating what is likely the world's biggest penile cancer biobank. View Profile

As a locum consultant in burn and plastic surgery at Manchester Foundation Trust, Riyadh has worked at a number of regional plastic surgery and burn units both domestically and abroad. He spent the majority of his experience in high turnover units, which greatly benefited his exposure and experience while he was employed at St. John's Hospital and in his previous positions. Dr. Riyadh Almasharqah has collaborated closely with numerous teams and has accumulated vast expertise performing solo and supervised operations on emergency and elective cases. Dr. Almasharqah has significant experience doing plastic surgery and laser rejuvenation treatments. View Profile

Hematologist and oncologist Adrian Bloor practices in London. He is employed by The Christie NHS Foundation Trust at the moment. He is the director of the stem cell transplant program, the departmental lead for lymphoid malignancies, and the clinical director of endocrinology, teenage and young adult cancer, and haematology. His credentials include an MA (Cantab), MB BChir, PhD, FRCP, and FRCPath. Hematology, lymphoma, leukemia, stem cell transplantation, cellular treatments, and CAR-T are among his areas of interest. Professor Bloor is particularly interested in clinical trials, CAR-T treatment, stem cell transplantation, and the management of lymphoid malignancies (such as CLL and lymphoma). From 2009 to 2015, he served as the clinical director of The Christie-based MAHSC (Manchester Academic Health Sciences Centre) clinical trials section. He is the principal or chief investigator for numerous trials in stem cell transplantation and hemato-oncology. He belongs to the University of Leeds CLL Trials Management Group, the NHS England Blood and Stem Cell Transplantation Clinical Reference Group, and the NCRI CLL Clinical Trials Committee. He serves on the Medical Advisory Panels for Lymphoma Action, Leukaemia Care, and Bloodwise, as well as the Executive Committee of the UK CLL Forum. View Profile